File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41590-019-0320-6
- Scopus: eid_2-s2.0-85061701202
- PMID: 30778243
- WOS: WOS:000465084800018
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
Title | Human CD8<sup>+</sup> T cell cross-reactivity across influenza A, B and C viruses |
---|---|
Authors | Koutsakos, MariosIlling, Patricia T.Nguyen, Thi H.O.Mifsud, Nicole A.Crawford, Jeremy ChaseRizzetto, SimoneEltahla, Auda A.Clemens, E. BridieSant, SnehaChua, Brendon Y.Wong, Chinn YiAllen, E. KaitlynnTeng, DonDash, PradyotBoyd, David F.Grzelak, LudivineZeng, WeiguangHurt, Aeron C.Barr, IanRockman, SteveJackson, David C.Kotsimbos, Tom C.Cheng, Allen C.Richards, MichaelWestall, Glen P.Loudovaris, ThomasMannering, Stuart I.Elliott, MichaelTangye, Stuart G.Wakim, Linda M.Rossjohn, JamieVijaykrishna, DhanasekaranLuciani, FabioThomas, Paul G.Gras, StephaniePurcell, Anthony W.Kedzierska, Katherine |
Issue Date | 2019 |
Citation | Nature Immunology, 2019, v. 20, n. 5, p. 613-625 How to Cite? |
Abstract | © 2019, The Author(s), under exclusive licence to Springer Nature America, Inc. Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally and infect humans, with IAV and IBV causing the most severe disease. CD8 + T cells confer cross-protection against IAV strains, however the responses of CD8 + T cells to IBV and ICV are understudied. We investigated the breadth of CD8 + T cell cross-recognition and provide evidence of CD8 + T cell cross-reactivity across IAV, IBV and ICV. We identified immunodominant CD8 + T cell epitopes from IBVs that were protective in mice and found memory CD8 + T cells directed against universal and influenza-virus-type-specific epitopes in the blood and lungs of healthy humans. Lung-derived CD8 + T cells displayed tissue-resident memory phenotypes. Notably, CD38 + Ki67 + CD8 + effector T cells directed against novel epitopes were readily detected in IAV- or IBV-infected pediatric and adult subjects. Our study introduces a new paradigm whereby CD8 + T cells confer unprecedented cross-reactivity across all influenza viruses, a key finding for the design of universal vaccines. |
Persistent Identifier | http://hdl.handle.net/10722/288591 |
ISSN | 2023 Impact Factor: 27.7 2023 SCImago Journal Rankings: 11.274 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koutsakos, Marios | - |
dc.contributor.author | Illing, Patricia T. | - |
dc.contributor.author | Nguyen, Thi H.O. | - |
dc.contributor.author | Mifsud, Nicole A. | - |
dc.contributor.author | Crawford, Jeremy Chase | - |
dc.contributor.author | Rizzetto, Simone | - |
dc.contributor.author | Eltahla, Auda A. | - |
dc.contributor.author | Clemens, E. Bridie | - |
dc.contributor.author | Sant, Sneha | - |
dc.contributor.author | Chua, Brendon Y. | - |
dc.contributor.author | Wong, Chinn Yi | - |
dc.contributor.author | Allen, E. Kaitlynn | - |
dc.contributor.author | Teng, Don | - |
dc.contributor.author | Dash, Pradyot | - |
dc.contributor.author | Boyd, David F. | - |
dc.contributor.author | Grzelak, Ludivine | - |
dc.contributor.author | Zeng, Weiguang | - |
dc.contributor.author | Hurt, Aeron C. | - |
dc.contributor.author | Barr, Ian | - |
dc.contributor.author | Rockman, Steve | - |
dc.contributor.author | Jackson, David C. | - |
dc.contributor.author | Kotsimbos, Tom C. | - |
dc.contributor.author | Cheng, Allen C. | - |
dc.contributor.author | Richards, Michael | - |
dc.contributor.author | Westall, Glen P. | - |
dc.contributor.author | Loudovaris, Thomas | - |
dc.contributor.author | Mannering, Stuart I. | - |
dc.contributor.author | Elliott, Michael | - |
dc.contributor.author | Tangye, Stuart G. | - |
dc.contributor.author | Wakim, Linda M. | - |
dc.contributor.author | Rossjohn, Jamie | - |
dc.contributor.author | Vijaykrishna, Dhanasekaran | - |
dc.contributor.author | Luciani, Fabio | - |
dc.contributor.author | Thomas, Paul G. | - |
dc.contributor.author | Gras, Stephanie | - |
dc.contributor.author | Purcell, Anthony W. | - |
dc.contributor.author | Kedzierska, Katherine | - |
dc.date.accessioned | 2020-10-12T08:05:21Z | - |
dc.date.available | 2020-10-12T08:05:21Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Nature Immunology, 2019, v. 20, n. 5, p. 613-625 | - |
dc.identifier.issn | 1529-2908 | - |
dc.identifier.uri | http://hdl.handle.net/10722/288591 | - |
dc.description.abstract | © 2019, The Author(s), under exclusive licence to Springer Nature America, Inc. Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally and infect humans, with IAV and IBV causing the most severe disease. CD8 + T cells confer cross-protection against IAV strains, however the responses of CD8 + T cells to IBV and ICV are understudied. We investigated the breadth of CD8 + T cell cross-recognition and provide evidence of CD8 + T cell cross-reactivity across IAV, IBV and ICV. We identified immunodominant CD8 + T cell epitopes from IBVs that were protective in mice and found memory CD8 + T cells directed against universal and influenza-virus-type-specific epitopes in the blood and lungs of healthy humans. Lung-derived CD8 + T cells displayed tissue-resident memory phenotypes. Notably, CD38 + Ki67 + CD8 + effector T cells directed against novel epitopes were readily detected in IAV- or IBV-infected pediatric and adult subjects. Our study introduces a new paradigm whereby CD8 + T cells confer unprecedented cross-reactivity across all influenza viruses, a key finding for the design of universal vaccines. | - |
dc.language | eng | - |
dc.relation.ispartof | Nature Immunology | - |
dc.title | Human CD8<sup>+</sup> T cell cross-reactivity across influenza A, B and C viruses | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1038/s41590-019-0320-6 | - |
dc.identifier.pmid | 30778243 | - |
dc.identifier.scopus | eid_2-s2.0-85061701202 | - |
dc.identifier.volume | 20 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 613 | - |
dc.identifier.epage | 625 | - |
dc.identifier.eissn | 1529-2916 | - |
dc.identifier.isi | WOS:000465084800018 | - |
dc.identifier.issnl | 1529-2908 | - |